Cresco Labs (CRLBF) Tax Provisions (2019 - 2026)
Cresco Labs (CRLBF) posted Tax Provisions of -$14.2 million for Q1 2026, down 688.25% on a QoQ basis from -$1.8 million in Q4 2025, and up 0.67% year-over-year from -$14.1 million in Q1 2025.
Cresco Labs (CRLBF) Tax Provisions (2019 - 2026) Analysis & Trends
Cresco Labs' Tax Provisions history runs 8 years deep, the most recent figure standing at -$14.2 million for Q1 2026.
- Quarterly Tax Provisions rose 0.67% year-over-year to -$14.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$44.5 million (up 3.59% YoY) and the FY2025 annual result came in at $44.6 million, down 10.53% from the prior year.
- Tax Provisions was -$14.2 million for Q1 2026 at Cresco Labs, down from -$1.8 million in the prior quarter.
- Across five years, Tax Provisions topped out at $5.7 million in Q3 2023 and bottomed at -$23.8 million in Q4 2022.
- A 5-year average of -$13.6 million and a median of -$14.3 million in 2025 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions soared 130.67% — and 2024, when it slumped 430.94%.
- Cresco Labs' Tax Provisions stood at -$23.8 million in 2022, then soared by 66.54% to -$8.0 million in 2023, then jumped by 67.09% to -$2.6 million in 2024, then soared by 31.04% to -$1.8 million in 2025, then tumbled by 688.25% to -$14.2 million in 2026.
- Business Quant data shows CRLBF's Tax Provisions at -$14.2 million in Q1 2026, -$1.8 million in Q4 2025, and -$11.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -14.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.22 Mn |
| Dec 31, 2025 | -1.80 Mn |
| Sep 30, 2025 | -11.87 Mn |
| Jun 30, 2025 | -16.64 Mn |
| Mar 31, 2025 | -14.32 Mn |
| Dec 31, 2024 | -2.62 Mn |
| Sep 30, 2024 | -19.02 Mn |
| Jun 30, 2024 | -10.24 Mn |
| Mar 31, 2024 | -18.00 Mn |
| Dec 31, 2023 | -7.95 Mn |
| Sep 30, 2023 | 5.75 Mn |
| Jun 30, 2023 | -13.94 Mn |
| Mar 31, 2023 | -16.81 Mn |
| Dec 31, 2022 | -23.76 Mn |
| Sep 30, 2022 | -18.73 Mn |
| Jun 30, 2022 | -23.64 Mn |
| Mar 31, 2022 | -22.81 Mn |
| Dec 31, 2021 | -23.53 Mn |
| Sep 30, 2021 | 9.86 Mn |
| Jun 30, 2021 | -13.46 Mn |